Lanino E - Search Results

1

Cytogenetic and molecular study of two human neuroblastoma cell lines.

Donti E, Longo L, Tonini GP, Verdona G, Melodia A, Lanino E, Cornaglia-Ferraris P. Donti E, et al. Among authors: lanino e. Cancer Genet Cytogenet. 1988 Feb;30(2):225-31. doi: 10.1016/0165-4608(88)90188-4. Cancer Genet Cytogenet. 1988. PMID: 3422578

2

MYCN amplification does not affect survival of neuroblastoma patients treated with autologous bone marrow transplantation.

Sansone R, Di Martino D, Lanino E, Dini G, Massimo L, Tonini GP. Sansone R, et al. Among authors: lanino e. Bone Marrow Transplant. 1991;7 Suppl 3:133-5. Bone Marrow Transplant. 1991. PMID: 1855077

3

Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.

Corrias MV, Cornaglia-Ferraris P, Di Martino D, Stenger AM, Lanino E, Boni L, Tonini GP. Corrias MV, et al. Among authors: lanino e. Anticancer Res. 1990 Jul-Aug;10(4):897-902. Anticancer Res. 1990. PMID: 1974410

4

Neuroblastoma cells circulate in peripheral blood.

Lanino E, Melodia A, Casalaro A, Cornaglia-Ferraris P. Lanino E, et al. Pediatr Hematol Oncol. 1989;6(2):193-5. doi: 10.3109/08880018909034286. Pediatr Hematol Oncol. 1989. PMID: 2702074 No abstract available.

5

MLL-MLLT10 fusion in acute monoblastic leukemia: variant complex rearrangements and 11q proximal breakpoint heterogeneity.

Morerio C, Rapella A, Rosanda C, Lanino E, Lo Nigro L, Di Cataldo A, Maserati E, Pasquali F, Panarello C. Morerio C, et al. Among authors: lanino e. Cancer Genet Cytogenet. 2004 Jul 15;152(2):108-12. doi: 10.1016/j.cancergencyto.2003.11.012. Cancer Genet Cytogenet. 2004. PMID: 15262427 Free article. Review.

6

Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine.

Garaventa A, Guerra P, Arrighini A, Bertolazzi L, Bestagno M, De Bernardi B, Lanino E, Villavecchia GP, Claudiani F. Garaventa A, et al. Among authors: lanino e. Cancer. 1991 Feb 15;67(4):922-8. doi: 10.1002/1097-0142(19910215)67:4<922::aid-cncr2820670411>3.0.co;2-d. Cancer. 1991. PMID: 1991264

7

Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.

Dini G, Lanino E, Rogers D, Garaventa A, Perin G, Stura M, Dallorso S, Cornaglia-Ferraris P, De Bernardi B. Dini G, et al. Among authors: lanino e. Med Pediatr Oncol. 1987;15(1):18-23. doi: 10.1002/mpo.2950150105. Med Pediatr Oncol. 1987. PMID: 3561328

8

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.

Garaventa A, Bellagamba O, Lo Piccolo MS, Milanaccio C, Lanino E, Bertolazzi L, Villavecchia GP, Cabria M, Scopinaro G, Claudiani F, De Bernardi B. Garaventa A, et al. Among authors: lanino e. Br J Cancer. 1999 Dec;81(8):1378-84. doi: 10.1038/sj.bjc.6694223. Br J Cancer. 1999. PMID: 10604736 Free PMC article. Clinical Trial.

9

Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

Castriconi R, Dondero A, Corrias MV, Lanino E, Pende D, Moretta L, Bottino C, Moretta A. Castriconi R, et al. Among authors: lanino e. Cancer Res. 2004 Dec 15;64(24):9180-4. doi: 10.1158/0008-5472.CAN-04-2682. Cancer Res. 2004. PMID: 15604290

10

Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.

Claudiani F, Stimamiglio P, Bertolazzi L, Cabria M, Conte M, Villavecchia GP, Garaventa A, Lanino E, De Bernardi B, Scopinaro G. Claudiani F, et al. Among authors: lanino e. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):21-4. Q J Nucl Med. 1995. PMID: 9002744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters